These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10464608)

  • 1. Establishing criteria for a carrier detection panel: lessons from the Ashkenazi Jewish model.
    Gilbert F
    Genet Test; 1998; 2(4):301-4. PubMed ID: 10464608
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA-based carrier screening in the Ashkenazi Jewish population.
    Zhang B; Dearing L; Amos J
    Expert Rev Mol Diagn; 2004 May; 4(3):377-92. PubMed ID: 15137904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic diseases and testing in Ashkenazi Jews: Part 1.
    Gilbert F
    Genet Test; 1997; 1(1):3-4. PubMed ID: 10464618
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatal genetic screening in the Ashkenazi Jewish population.
    Zinberg RE; Kornreich R; Edelmann L; Desnick RJ
    Clin Perinatol; 2001 Jun; 28(2):367-82. PubMed ID: 11499058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities.
    Hoffman JD; Park JJ; Schreiber-Agus N; Kornreich R; Tanner AK; Keiles S; Friedman KJ; Heim RA
    Prenat Diagn; 2014 Dec; 34(12):1161-7. PubMed ID: 24996053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
    Ferreira JC; Schreiber-Agus N; Carter SM; Klugman S; Gregg AR; Gross SJ
    Am J Obstet Gynecol; 2014 Sep; 211(3):197-204. PubMed ID: 24508465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial dysautonomia and the expansion of the Ashkenazi Jewish carrier screening panel.
    Gilbert F
    Genet Test; 2001; 5(2):83-5. PubMed ID: 11551107
    [No Abstract]   [Full Text] [Related]  

  • 8. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier screening panels for Ashkenazi Jews: is more better?
    Leib JR; Gollust SE; Hull SC; Wilfond BS
    Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ashkenazi Jewish genetic disorders.
    Charrow J
    Fam Cancer; 2004; 3(3-4):201-6. PubMed ID: 15516842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
    Holtkamp KC; van Maarle MC; Schouten MJ; Dondorp WJ; Lakeman P; Henneman L
    Eur J Hum Genet; 2016 Feb; 24(2):171-7. PubMed ID: 25966636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic profile of contemporary Jewish populations.
    Ostrer H
    Nat Rev Genet; 2001 Nov; 2(11):891-8. PubMed ID: 11715044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selected genetic disorders affecting Ashkenazi Jewish families.
    Weinstein LB
    Fam Community Health; 2007; 30(1):50-62. PubMed ID: 17149032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendation of premarital genetic screening in the Syrian Jewish community based on mutation carrier frequencies within Syrian Jewish cohorts.
    Zeevi DA; Chung WK; Levi C; Scher SY; Bringer R; Kahan Y; Muallem H; Benel R; Hirsch Y; Weiden T; Ekstein A; Ekstein J
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1756. PubMed ID: 34288589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of carriers in the Ashkenazi Jewish population: an objective comparison of high-throughput genotyping versus gene-by-gene testing.
    Klugman S; Schreiber-Agus N; Nazareth S; Evans EA
    Genet Test Mol Biomarkers; 2013 Oct; 17(10):763-7. PubMed ID: 23952016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
    Roa BB; Savino CV; Richards CS
    Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
    Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
    Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
    Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.